British Patient Capital reported total fund commitments of £2.3 billion and aims to strengthen venture capital investment in the UK, focusing on life sciences and technology sectors, while also addressing existing funding gaps.

Target Information

British Patient Capital is recognized as the largest domestic investor in venture capital and venture growth capital in the UK, with total fund and co-investment commitments reaching £2.3 billion as of March 31, 2024. It has significantly expanded its portfolio, committing £381 million during the year, of which £296 million was allocated from its core funds and co-investment programs. The firm has built a diverse portfolio comprising 44 different fund managers and an underlying network of 1,350 companies, marking an increase of 162 companies from the previous year.

In the fiscal year 2023/24, British Patient Capital successfully made 10 new fund commitments and five new co-investments through its core program. Additionally, it executed 10 direct investments via the Future Fund: Breakthrough initiative, amounting to a total of £66 million. Overall investments since the inception of British Patient Capital have totaled £2.287 billion, encompassing 80 fund commitments, 10 co-investments, and 18 Future Fund: Breakthrough deals.

Industry Overview in the UK

The UK venture capital landscape has been experiencing notable growth in recent years, as highlighted by an analysis from the British Business Bank, which indicates that the UK has reduced its venture capital investment gap with th